Clinical trial
A Prospective Study to Evaluate the WatchPAT in Comparison to Polysomnography (PSG) Gold Standard in Patients Suspected of Sleep Disorders
NCT06093633 is registered in ClinicalTrials.gov with Itamar-Medical, Israel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study to Evaluate the WatchPAT in Comparison to Polysomnography (PSG) Gold Standard in Patients Suspected of Sleep Disorders
- Lead sponsor
- Itamar-Medical, Israel
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 19, 2022
- Completion date
- October 1, 2025
- Enrollment
- 600 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
sleep disorder